|BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV DamageMutation Load in BRAF/NRAS Wild-Type Melanomas|
VJ Mar, SQ Wong, J Li, RA Scolyer, C McLean, AT Papenfuss, RW Tothill, ...
Clinical Cancer Research 19 (17), 4589-4598, 2013
|Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia|
V Mar, H Roberts, R Wolfe, DR English, JW Kelly
Journal of the American Academy of Dermatology 68 (4), 568-575, 2013
|Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA|
L Tan, S Sandhu, RJ Lee, J Li, J Callahan, S Ftouni, N Dhomen, ...
Annals of Oncology 30 (5), 804-814, 2019
|Clinical and pathological associations of the activating RAC1 P29S mutation in primary cutaneous melanoma|
VJ Mar, SQ Wong, A Logan, T Nguyen, J Cebon, JW Kelly, R Wolfe, ...
Pigment cell & melanoma research 27 (6), 1117-1125, 2014
|Diagnostic accuracy of malignant melanoma according to subtype|
MJ Lin, V Mar, C McLean, R Wolfe, JW Kelly
Australasian Journal of Dermatology 55 (1), 35-42, 2014
|Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma|
SQ Wong, A Behren, VJ Mar, K Woods, J Li, C Martin, KE Sheppard, ...
Oncotarget 6 (2), 1115, 2015
|Artificial intelligence for melanoma diagnosis: how can we deliver on the promise?|
VJ Mar, HP Soyer
Annals of Oncology 29 (8), 1625-1628, 2018
|Predicting melanoma risk for the Australian population|
V Mar, R Wolfe, JW Kelly
Australasian journal of dermatology 52 (2), 109-116, 2011
|Tumour mutation status and sites of metastasis in patients with cutaneous melanoma|
NR Adler, R Wolfe, JW Kelly, A Haydon, GA McArthur, CA McLean, ...
British journal of cancer 117 (7), 1026-1035, 2017
|Metastatic pathways in patients with cutaneous melanoma|
NR Adler, A Haydon, CA McLean, JW Kelly, VJ Mar
Pigment Cell & Melanoma Research 30 (1), 13-27, 2017
|Scalp melanoma: distinctive high risk clinical and histological features|
C Xie, Y Pan, C McLean, V Mar, R Wolfe, JW Kelly
Australasian Journal of Dermatology 58 (3), 181-188, 2017
|The role of BRAF mutations in primary melanoma growth rate and survival|
VJ Mar, W Liu, B Devitt, SQ Wong, A Dobrovic, GA McArthur, R Wolfe, ...
British Journal of Dermatology 173 (1), 76-82, 2015
|The increasing use of shave biopsy for diagnosing invasive melanoma in Australia|
SL de Menezes, JW Kelly, R Wolfe, H Farrugia, VJ Mar
Medical Journal of Australia 211 (5), 213-218, 2019
|Clinical practice guidelines for the diagnosis and management of melanoma: melanomas that lack classical clinical features|
VJ Mar, AJ Chamberlain, JW Kelly, WK Murray, JF Thompson
Medical Journal of Australia 207 (8), 348-350, 2017
|Early detection of melanoma: a consensus report from the Australian skin and skin cancer research centre melanoma screening Summit|
M Janda, AE Cust, RE Neale, JF Aitken, PD Baade, AC Green, ...
Australian and New Zealand journal of public health 44 (2), 111-115, 2020
|Impact of scalp location on survival in head and neck melanoma: a retrospective cohort study|
C Xie, Y Pan, C McLean, V Mar, R Wolfe, J Kelly
Journal of the American Academy of Dermatology 76 (3), 494-498. e2, 2017
|An objective measure of growth rate using partial biopsy specimens of melanomas that were initially misdiagnosed|
MJ Lin, V Mar, C McLean, JW Kelly
Journal of the American Academy of Dermatology 71 (4), 691-697, 2014
|Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: a virtual appliance approach for instant deployment|
J Li, MA Doyle, I Saeed, SQ Wong, V Mar, DL Goode, F Caramia, K Doig, ...
PloS one 9 (4), e95217, 2014
|Clinicopathological characteristics associated with BRAFK601E and BRAFL597 mutations in melanoma|
M Voskoboynik, V Mar, S Mailer, A Colebatch, A Fennessy, A Logan, ...
Pigment cell & melanoma research 29 (2), 222-228, 2016
|Hand dermatitis and lymphoedema|
VJ Pearce, PS Mortimer
British Journal of Dermatology 161 (1), 177-180, 2009